Precontrast T1 signal measurements of normal pituitary and microadenoma: A retrospective analysis through DCE MRI signal time curves

Abstract

Background: The dynamic contrast enhanced magnetic resonance imaging (DCE MRI) has currently become the most utilized technique for the detection of pituitary microadenoma. However, owing to differential enhancement of normal pituitary, high rate of false positivity remains a concern in its interpretation. Purpose: Our aim was to assess the utility of precontrast T1 signal intensity ratio (SIR) of the lesions suspected on DCE MRI, in prediction of presence of microadenoma. Materials and Methods: We retrospectively reviewed MRI of 23 patients referred for DCE MRI of pituitary (group 1, 15 patients with diagnosis of pituitary microadenoma; and group 2, patients not clinically labeled as microadenoma). STC were plotted and T1-SIR at t = 0 s was obtained at the suspicious zone of differential enhancement (SIR T) and normal pituitary (SIR P). SIR difference (SIR P − SIR T) and relative SIR difference (SIR P − SIR T/SIR P) were calculated for each patient and was compared between the two groups. Results: Mean T1 SIR is lower in patients with microadenoma than those without (P = 0.065). SIR difference and relative SIR difference was higher in patients with microadenoma (P = 0.003 and 0.005, respectively). Receiver-operated characteristic curve analysis demonstrated that a cut-off of 26 and 0.107 for SIR difference and relative SIR difference, respectively, could diagnose microadenoma with 100% specificity and reasonable sensitivities. Conclusion: The baseline precontrast T1 SIR evaluation of the lesion suspected to be microadenoma on DCE MRI, derived through STC curve, can increase diagnostic confidence in diagnosis of microadenoma.

Keywords

Dynamic contrast magnetic resonance imaging - pituitary microadenoma - signal time curve

Publikationsverlauf

Artikel online veröffentlicht:
26. Juli 2021

• References

• 1 Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML. et al. The prevalence of pituitary adenomas: A systematic review. Cancer 2004; 101: 613-9
• 2 Chaudhry IN, Sinaii N, Oldfeild EH, Patronas N, Nieman LK. A change in pituitary magnetic resonance imaging protocol detects ACTH-secreting tumours in patient with previously negative results. Clin Endocrinol (Oxf) 2010; 72: 502-6
• 3 Kasaliwal R, Sankhe SS, Lila AR. Volume interpolated 3D-spoiled gradient echo sequence is better than dynamic contrast spin echo sequence for MRI detection of corticotropin secreting pituitary microadenomas. Clin Endocrinol 2013; 78: 825-30
• 4 Hemminghytt S, Kalkhoff RK, Daniels DL, Williams AL, Grogan JP, Haughton VM. Computed tomographic study of hormone-secreting microadenomas. Radiology 1983; 46: 65-9
• 5 Miki Y, Michimasa M, Nishizawa S, Kuroda Y, Keyaki A, Makita Y. et al. Pituitary adenomas and normal pituitary tissue: Enhancement patterns on gadopentetate-enhanced MR imaging. Radiology 1990; 177: 35-8
• 6 Bartynski WS, Lin L. Dynamic and conventional spin-echo MR of pituitary microlesions. Am J Neuroradiol 1997; 18: 965-72
• 7 Tabarin A, Laurent F, Catargi B, Olivier-Puel F, Lescene R, Berge J. et al. Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing’s disease. Clin Endocrinol 1998; 49: 293-300
• 8 Doppman JL, Frank JA, Dwyer AJ, Oldfield EH, Miller DL, Nieman LK. et al. Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland. J Comput Assist Tomogr 1988; 12: 728-35
• 9 Kucharczyk W, Davis DO, Kelly WM, Sze G, Norman D, Newton TH. et al. Pituitary adenomas: High- resolution MR imaging at 1.5 T. Radiology 1986; 161: 761-5
• 10 Yuh WT, Fisher DJ, Nguyen HD, Tali ET, Gao F, Simonson TM. et al. Sequential MR enhancement pattern in normal pituitary gland and in pituitary adenoma. Am J Neuroradiol 1994; 15: 101-8
• 11 Rossi Espagnet MC, Bangiyev L, Haber M, Block KT, Babb J, Ruggiero V. et al. High-resolution DCE-MRI of the pituitary gland using radial k-Space acquisition with compressed sensing reconstruction. Am J Neuroradiol 2015; 36: 1444-9
• 12 Stadnik T, Stevenaert A, Beckers A, Luypaert R, Buisseret T, Osteaux M. Pituitary microadenomas: Diagnosis with two- and three-dimensional MR imaging at 1.5 T before and after injection of gadolinium. Radiology 1990; 176: 419-28
• 13 Ma Z, He W, Zhao Y, Yuan J, Zhang Q, Wu Y. et al. Predictive value of PWI for blood supply and T1-spin echo MRI for consistency of pituitary adenoma. Neuroradiology 2016; 58: 51-7
• 14 Pojunas KW, Daniels DL, Williams A, Haughton VM. MR imaging of prolactin-secreting microadenomas. Am J Neuroradiol 1986; 7: 209-13